Rep. Rita Mayfield
Filed: 4/8/2013
 
 

 

 

 
09800HB0702ham001LRB098 03526 JDS 44047 a



1
AMENDMENT TO HOUSE BILL 702 




2    AMENDMENT NO. ______. Amend House Bill 702 by replacing 
3everything after the enacting clause with the following:

 
4    "Section 5. The Environmental Protection Act is amended  by 
5changing Section 3.360 as follows:
 



6    (415 ILCS 5/3.360)  (was 415 ILCS 5/3.84)



7    Sec. 3.360. Potentially infectious medical waste. 

8    (a) "Potentially infectious medical waste" means
the 
9following types of waste generated in connection with the 
10diagnosis,
treatment (i.e., provision of medical services), or 
11immunization of
human beings or animals; research pertaining to 
12the provision of medical
services; or the production or testing 
13of biologicals:


14        (1) Cultures and stocks.
This waste shall include but 
15    not be limited to cultures and stocks of
agents infectious 
16    to humans, and associated biologicals; cultures from

 
 
09800HB0702ham001- 2 -LRB098 03526 JDS 44047 a

1    medical or pathological laboratories; cultures and stocks 
2    of infectious
agents from research and industrial 
3    laboratories; wastes from the
production of biologicals; 
4    discarded live or attenuated vaccines; or
culture dishes 
5    and devices used to transfer, inoculate, or mix cultures.


6        (2) Human pathological wastes.  This waste shall 
7    include tissue, organs,
and body parts (except teeth and 
8    the contiguous
structures of bone and gum); body fluids 
9    that are removed during surgery,
autopsy, or other medical 
10    procedures; or specimens of body fluids and their

11    containers.


12        (3) Human blood and blood products.  This waste shall 
13    include discarded
human blood, blood components (e.g., 
14    serum and plasma), or saturated material
containing free 
15    flowing blood or blood components.


16        (4) Used sharps.  This waste shall include but not be 
17    limited to
discarded sharps used in animal or human patient 
18    care, medical
research, or clinical or pharmaceutical 
19    laboratories; hypodermic,
intravenous, or other medical

20    needles; hypodermic or intravenous syringes; Pasteur 
21    pipettes; scalpel
blades; or blood vials.  This waste shall 
22    also include but not be limited
to other types of broken or 
23    unbroken glass (including slides and cover
slips) in 
24    contact with infectious agents.


25        (5) Animal waste.  Animal waste means discarded 
26    materials, including
carcasses, body parts, body fluids, 
 
 
09800HB0702ham001- 3 -LRB098 03526 JDS 44047 a

1    blood, or bedding originating from animals
inoculated 
2    during research, production of biologicals, or 
3    pharmaceutical
testing with agents infectious to humans.


4        (6) Isolation waste.  This waste shall include 
5    discarded materials
contaminated with blood, excretions, 
6    exudates, and secretions from humans
that are isolated to 
7    protect others from highly communicable diseases.
"Highly 
8    communicable diseases" means those diseases identified by 
9    the Board
in rules adopted under subsection (e) of Section 
10    56.2 of this Act.


11        (7) Unused sharps.  This waste shall include but not be 
12    limited to the
following unused, discarded sharps: 
13    hypodermic, intravenous, or
other needles; hypodermic or 
14    intravenous syringes; or scalpel blades. 

15    (b) Potentially infectious medical waste does not include:


16        (1) waste generated as general household waste;


17        (2) waste (except for sharps) for which the infectious 
18    potential has
been eliminated by treatment; or


19        (3) sharps that meet both of the following conditions:


20            (A) the infectious potential has been eliminated 
21        from the sharps by
treatment; and


22            (B) the sharps are packaged in accordance with 
23        Board regulations the sharps are rendered 
24        unrecognizable by treatment.

25(Source: P.A. 92-574, eff. 6-26-02.)".